Cargando…

The critical role of epigenetic mechanism in PM(2.5)-induced cardiovascular diseases

Cardiovascular disease (CVD) has become the leading cause of death worldwide, which seriously threatens human life and health. Epidemiological studies have confirmed the occurrence and development of CVD are closely related to air pollution. In particular, fine particulate matter (PM(2.5)) is recogn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qinglin, Ren, Xiaoke, Sun, Zhiwei, Duan, Junchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518296/ https://www.ncbi.nlm.nih.gov/pubmed/34654488 http://dx.doi.org/10.1186/s41021-021-00219-w

Ejemplares similares

The mitochondria-targeted antioxidant MitoQ attenuated PM(2.5)-induced vascular fibrosis via regulating mitophagy
por: Ning, Ruihong, et al.
Publicado: (2021)

An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework
por: Ding, Ruiyang, et al.
Publicado: (2022)

Melatonin ameliorates PM(2.5)‐induced cardiac perivascular fibrosis through regulating mitochondrial redox homeostasis
por: Jiang, Jinjin, et al.
Publicado: (2020)

Melatonin Alleviates PM(2.5)-Induced Hepatic Steatosis and Metabolic-Associated Fatty Liver Disease in ApoE(−/−) Mice
por: Du, Zhou, et al.
Publicado: (2022)

Repeat dose exposure of PM(2.5) triggers the disseminated intravascular coagulation (DIC) in SD rats
por: Liang, Shuang, et al.
Publicado: (2019)

The Role of Metal Components in the Cardiovascular Effects of PM(2.5)
por: Niu, Jingping, et al.
Publicado: (2013)

EPA's PM2.5 program criticized.
Publicado: (1998)

PM(2.5) and Cardiovascular Diseases in the Elderly: An Overview
por: Wang, Chenchen, et al.
Publicado: (2015)

The contribution of PM(2.5) to cardiovascular disease in China
por: Zhang, Shuqi, et al.
Publicado: (2020)

Research on PM(2.5) concentration based on dissipative structure theory: a case study of Xi’an, China
por: Sun, Xiaoke, et al.
Publicado: (2020)

Role of PM(2.5) in the development and progression of COPD and its mechanisms
por: Zhao, Junling, et al.
Publicado: (2019)

PM(2.5) and cardiovascular diseases: State-of-the-Art review
por: Krittanawong, Chayakrit, et al.
Publicado: (2023)

Cardiotoxicity and Mechanism of Particulate Matter 2.5 (PM2.5) Exposure in Offspring Rats During Pregnancy
por: Wang, Hongling, et al.
Publicado: (2017)

Cardiovascular, respiratory, and total mortality ascribed to PM(10) and PM(2.5) exposure in Isfahan, Iran
por: Abdolahnejad, Ali, et al.
Publicado: (2017)

The critical role of endothelial function in fine particulate matter-induced atherosclerosis
por: Liang, Shuang, et al.
Publicado: (2020)

Astaxanthin alleviates PM(2.5)-induced cardiomyocyte injury via inhibiting ferroptosis
por: Ren, Jingyi, et al.
Publicado: (2023)

Race or racial segregation? Modification of the PM(2.5) and cardiovascular mortality association
por: Yitshak-Sade, Maayan, et al.
Publicado: (2020)

The burden of cardiovascular disease associated with PM2.5 exposure in the Portuguese population
por: Martins, C, et al.
Publicado: (2023)

Magnetic Fractions of PM(2.5), PM(2.5–10), and PM(10) from Coal Fly Ash as Environmental Pollutants
por: Fomenko, Elena V., et al.
Publicado: (2021)

Epitranscriptomic 5-Methylcytosine Profile in PM(2.5)-induced Mouse Pulmonary Fibrosis
por: Han, Xiao, et al.
Publicado: (2020)

Efficiency of tourism development in China’s major cities under the constraint of PM2.5
por: Li, Jiajia, et al.
Publicado: (2021)

PM(2.5) on the London Underground
por: Smith, J.D., et al.
Publicado: (2020)

Characterization and Cytotoxicity of PM(<0.2), PM(0.2–2.5) and PM(2.5–10) around MSWI in Shanghai, China
por: Cao, Lingling, et al.
Publicado: (2015)

Critical supply chains for mitigating PM(2.5) emission-related mortalities in India
por: Mitoma, Haruka, et al.
Publicado: (2021)

Association of PM(2.5) exposure with hospitalization for cardiovascular disease in elderly individuals in Japan
por: Kaihara, Toshiki, et al.
Publicado: (2021)

Exposure to PM2.5 and cardiovascular diseases in Portugal – the contribute of PMCardImpact project
por: Martins, C, et al.
Publicado: (2022)

Health Risk Assessment of PM(2.5) and PM(2.5)-Bound Trace Elements in Thohoyandou, South Africa
por: Edlund, Karl Kilbo, et al.
Publicado: (2021)

PM2.5-induced cardiovascular dysregulation in rats is associated with elemental carbon and temperature-resolved carbon subfractions
por: Wagner, James G, et al.
Publicado: (2014)

PM10, PM2.5, PM1, and PM0.1 resuspension due to human walking
por: Benabed, Ahmed, et al.
Publicado: (2022)

Is Ambient PM(2.5) Sulfate Harmful?
por: Grahame, Thomas, et al.
Publicado: (2012)

Variability analysis in PM2.5 monitoring
por: Bhardwaj, Rashmi, et al.
Publicado: (2019)

Fatal PM(2.5) and O(3)
por: Chung, Min Suk
Publicado: (2019)

Contribution of on-road transportation to PM(2.5)
por: Li, Chao, et al.
Publicado: (2021)

PM(2.5) and Diabetes in the Japanese Population
por: Lee, Mihye, et al.
Publicado: (2021)

Effect of ambient fine particulates (PM(2.5)) on hospital admissions for respiratory and cardiovascular diseases in Wuhan, China
por: Ren, Zhan, et al.
Publicado: (2021)

Cumulative effect of PM(2.5) components is larger than the effect of PM(2.5) mass on child health in India
por: Chaudhary, Ekta, et al.
Publicado: (2023)

Association of physical activity and PM2.5-attributable cardiovascular disease mortality in the United States
por: Liu, Yingying, et al.
Publicado: (2023)

PM(2.5) in Beijing – temporal pattern and its association with influenza
por: Liang, Yijia, et al.
Publicado: (2014)

PM(2.5) Cooperative Control with Fuzzy Cost and Fuzzy Coalitions
por: Zhou, Zhen, et al.
Publicado: (2019)

PM2.5 Exposure and Asthma Development: The Key Role of Oxidative Stress
por: Liu, Kaimeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6tde1ioj19nhg913dkh6b2619